Terms: = Lung cancer AND EML4, ENSG00000143924, 27436 AND Staging
6 results:
1. Protocol to Improve Genotyping of Non-Small-Cell lung cancer Diagnosed Using EBUS-TBNA.
Bellinger CR; Sharma D; Dotson T; Ruiz J; Parks G; Haponik EF
South Med J; 2018 Oct; 111(10):601-606. PubMed ID: 30285266
[TBL] [Abstract] [Full Text] [Related]
2. Correlation between eml4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.
Wang H; Zhang W; Wang K; Li X
Medicine (Baltimore); 2018 Jun; 97(26):e11116. PubMed ID: 29952952
[TBL] [Abstract] [Full Text] [Related]
3. Dual drive coexistence of eml4-ALK and TPM3-ROS1 fusion in advanced lung adenocarcinoma.
Zhu YC; Liao XH; Wang WX; Xu CW; Zhuang W; Wei JG; Du KQ
Thorac Cancer; 2018 Feb; 9(2):324-327. PubMed ID: 29251824
[TBL] [Abstract] [Full Text] [Related]
4. Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma.
Verso M; Chiari R; Mosca S; Franco L; Fischer M; Paglialunga L; Bennati C; Scialpi M; Agnelli G
Thromb Res; 2015 Nov; 136(5):924-7. PubMed ID: 26377037
[TBL] [Abstract] [Full Text] [Related]
5. Recurrence of lung adenocarcinoma after an interval of 15 years revealed by demonstration of the same type of eml4-ALK fusion gene.
Tsukamoto Y; Kanamori K; Watanabe T; Mikami K; Ieki R; Nakano T; Kajimoto K; Hirota S
Pathol Res Pract; 2014 Dec; 210(12):1112-6. PubMed ID: 25238939
[TBL] [Abstract] [Full Text] [Related]
6. lung cancer management in 2010.
Ganti AK; Huang CH; Klein MA; Keefe S; Kelley MJ
Oncology (Williston Park); 2011 Jan; 25(1):64-73. PubMed ID: 21361246
[TBL] [Abstract] [Full Text] [Related]
